Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Current Liabilities (2016 - 2025)

Rockwell Medical's Total Current Liabilities history spans 16 years, with the latest figure at $9.6 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 32.01% year-over-year to $9.6 million; the TTM value through Dec 2025 reached $9.6 million, down 32.01%, while the annual FY2025 figure was $9.6 million, 32.01% down from the prior year.
  • Total Current Liabilities reached $9.6 million in Q4 2025 per RMTI's latest filing, roughly flat from $9.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $34.0 million in Q2 2021 to a low of $9.6 million in Q4 2025.
  • Average Total Current Liabilities over 5 years is $16.7 million, with a median of $15.9 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 196.11% in 2021, then crashed 45.55% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $21.0 million in 2021, then decreased by 15.62% to $17.7 million in 2022, then decreased by 5.96% to $16.6 million in 2023, then dropped by 15.3% to $14.1 million in 2024, then tumbled by 32.01% to $9.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Total Current Liabilities are $9.6 million (Q4 2025), $9.6 million (Q3 2025), and $10.9 million (Q2 2025).